Cargando…
PGLYRP2 as a novel biomarker for the activity and lipid metabolism of systemic lupus erythematosus
BACKGROUND: To assess the value of peptidoglycan recognition protein 2 (PGLYRP2) in assessing the disease activity and lipid metabolism in patients with systemic lupus erythematosus (SLE). METHODS: SLE patients with stable disease (n = 15), active lupus nephritis (LN) (n = 15) and neuropsychiatric s...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8404349/ https://www.ncbi.nlm.nih.gov/pubmed/34461924 http://dx.doi.org/10.1186/s12944-021-01515-8 |